Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 10Breast Neoplasms 6Recurrence 4Lymphoma, Non-Hodgkin 4Leukemia, Myeloid, Acute 4Hematologic Neoplasms 4Wilms Tumor 3Solid Tumor 3Neuroblastoma 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Basal Cell 3Testicular Neoplasms 2Skin Neoplasms 2Sezary Syndrome 2Prostatic Neoplasms 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neutropenia 2Mycosis Fungoides 2Mycoses 2Medical Oncology 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2

Interventions

Pemetrexed 23Cisplatin 19Nivolumab 8Gemcitabine 7Ipilimumab 6Carboplatin 6pembrolizumab 4Bevacizumab 4tazemetostat 3durvalumab 3Fluorouracil 3Drug Therapy 3spartalizumab 2olaparib 2niraparib 2budigalimab 2belinostat 2anetumab ravtansine 2amatuximab 2Vinorelbine 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2PM 01183 2Oxaliplatin 2Imatinib Mesylate 2Everolimus 2Erlotinib Hydrochloride 2Doxorubicin 2Cyclophosphamide 2venetoclax 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mesothelioma × Itraconazole × Clear all
NCT04537715 2025-02-19

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

Ipsen

Phase 1 Completed
42 enrolled 39 charts
LymphoidOther hematologic neoplasmOther solid neoplasmSarcomaThoracic

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Sarcoma, Synovial, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡